Page last updated: 2024-09-03

omega-n-methylarginine and aliskiren

omega-n-methylarginine has been researched along with aliskiren in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(aliskiren)
Trials
(aliskiren)
Recent Studies (post-2010) (aliskiren)
4,411344336978211611

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)aliskiren (IC50)
ReninHomo sapiens (human)0.001
Renin-1 Mus musculus (house mouse)0.0045
Renin Rattus norvegicus (Norway rat)0.084
Cytochrome P450 3A4Homo sapiens (human)0.0004
Cytochrome P450 2C9 Homo sapiens (human)0.0023
ReninMacaca mulatta (Rhesus monkey)0.0012
Renin Oryctolagus cuniculus (rabbit)0.011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernini, G; Bruno, RM; Cartoni, G; Duranti, E; Ghiadoni, L; Lorenzini, G; Qasem, AA; Taddei, S; Virdis, A1

Trials

1 trial(s) available for omega-n-methylarginine and aliskiren

ArticleYear
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
    European heart journal, 2012, Volume: 33, Issue:12

    Topics: Adult; Amides; Antihypertensive Agents; Arterioles; Blood Flow Velocity; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Fumarates; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Ramipril; Vascular Resistance; Vascular Stiffness; Vasodilator Agents

2012